Alyeska Investment Group, L.P. Bridge Bio Pharma, Inc. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 940,415 shares of BBIO stock, worth $32.8 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
940,415Holding current value
$32.8 Million% of portfolio
0.1%Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
315Shares Held
177MCall Options Held
11.2MPut Options Held
2.29M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$882 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$877 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$526 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$434 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$216 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.17B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...